Maybe this is the end of long-term stomach aches and pains, at least for patients with Crohn's disease who don't respond to the common treatment.

Beyond the red, itchy patches in patients with psoriasis, other problems may lay beneath their skin.

What happens on the outside can affect us on the inside. And it happens both ways, specifically among patients with psoriasis and inflammatory bowel diseases.

For psoriasis patients, all kinds of options are available to treat the red and irritated skin. Some treatments have more benefits than others, including how it affects your risk for heart attacks.

Mind over matter can certainly have an effect on the body. Relaxation techniques, habit reversal, and cognitive behavioral therapy can now help beyond stress control and anxiety.

Psoriasis has been linked to a number of other health problems, including metabolic syndrome (a set of risk factors for heart disease and diabetes). Now, the link between psoriasis and diabetes has become clearer.

People taking immunity-suppressing drugs are currently advised against the live-virus shingles vaccine because there is concern that it could lead to shingles, for this population.

Those suffering from psoriasis are known to be at increased risk of cardiovascular disease like heart attack and stroke. A new treatment for psoriasis may also significantly decrease the cardiovascular risk. In the treatment, a compound known as adalimumab (sold as Humira ) is injected under the skin. The findings were presented at the annual meeting of the American Academy of Dermatology and showed that the treatment decreased skin damage and improved cardiovascular health indicators. Ask your dermatologist about psoriasis’ relation with cardiovascular disease. Robert Bissonn...

Psoriatic arthritis is a painful condition that, sadly enough, has no cure. The good news is patients can find relief from a variety of treatments, including medications and surgery.

Research into treating breast cancer may have also stumbled onto a way to treat psoriasis. The two conditions share a protein that, if blocked, may reduce the intensity of both diseases.